Non-classic congenital adrenal hyperplasia

Pediatric Endocrinology Reviews

Volumn 3, Issue SUPPL. 3, 2006, Pages 451-454

  Kelestimur, Fahrettin ^a  

^a ERCIYES UNIVERSITY   (Turkey)

Author keywords

Hirsutism; Non Classic Adrenal Hyperplasia

Indexed keywords

ALDOSTERONE; ANTIANDROGEN; CORTICOTROPIN; CYPROTERONE ACETATE; CYTOCHROME; CYTOCHROME P450 21A1P; FINASTERIDE; FLUTAMIDE; GLUCOCORTICOID; GONADORELIN AGONIST; HYDROCORTISONE; HYDROXYPROGESTERONE; PRASTERONE; SPIRONOLACTONE; STEROID 11BETA MONOOXYGENASE; STEROID 21 MONOOXYGENASE; STEROID 5ALPHA REDUCTASE INHIBITOR; UNCLASSIFIED DRUG;

ADRENAL FUNCTION; ARTICLE; CHROMOSOME 6P; CLINICAL FEATURE; CONGENITAL ADRENAL HYPERPLASIA; CORTICOTROPIN TEST; DIAGNOSTIC TEST; ENZYME DEFICIENCY; GENE MUTATION; HIRSUTISM; HUMAN; HYPERANDROGENISM; INFERTILITY; OVARY POLYCYSTIC DISEASE; OVULATION INDUCTION; PSEUDOGENE; STEROID 11BETA MONOOXYGENASE DEFICIENCY; STEROID 21 MONOOXYGENASE DEFICIENCY; UNSPECIFIED SIDE EFFECT;

ADOLESCENT; ADRENAL HYPERPLASIA, CONGENITAL; ADRENOCORTICOTROPIC HORMONE; ADULT; ANDROGEN ANTAGONISTS; CHILD; FEMALE; HIRSUTISM; HUMANS; HYDROCORTISONE; INFANT, NEWBORN; INFERTILITY; MALE; STEROID 21-HYDROXYLASE;

EID: 33750986186     PISSN: 15654753     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Azziz R, Rafi A, Smith BR, Bradley ER, Zacur HA. On the origin of the elevated 17-hydroxyprogesterone levels after adrenal stimulation in hyperandrogenism. J Clin Endocrinol Metab 1990;70:431-436
2. Speiser PW. Congenital adrenal hyperplasia owing to 21-hydroxylase deficiency. Endocrinol Metab Clin North America 2001;30:31-59
3. Speiser PW, Dupont B, Rubinstein P, Piazza A, Kastelan A, New MI. High frequency of nonclassical steroid 21-hydroxylase deficiency. Am J Hum Gen 1985;37:650-667
4. Dolzan V, Prezelj J, Vidan-Jeras B, Breskvar K. Adrenal 21-hydroxylase gene mutations in Slovenian hyperandrogenic women: evaluation of corticotrophin stimulation and HLA polymorphisms in screening for carrier status. Eur J Endocrinol 1999;141:132-139
5. Kuttenn F, Couillin P. Girard F, Billaud L, Vincens M, Boucekkine C, Thalabard JC, Maudelonde T, Spritzer P, Mowszowicz I. Late-onset adrenal hyperplasia in hirsutism. N Engl J Med 1985;313:224-231
6. Carmina E, Rosato F, Janni A, Rizzo M, Longo RA. Relative prevalence of different androgen excess disorders in 950 women referred because of clinical hyperandrogenism. J Clin Endocrinol Metab 2006;91:2-6
7. Akinci A, Yordam N, Ersoy F, UluSahin N, Oǧuz H. The incidence of nonclassical 21-hydroxylase deficiency in hirsute adolescent girls. Gynecol Endocrinol 1992;6:99-106
8. Kamel N, Tonyukuk V, Emral R, Çorapçioglu D, Baştemir M, Güllü S. The prevalence of late onset congenital adrenal hyperplasia in hirsute women from central Anatolia. Endocrine J 2003;50:815-823
9. Sahin Y, Kelestimur F. The frequency of late-onset 21-hydroxylase and 11 beta-hydroxylase deficiency in women with polycystic ovary syndrome. Eur J Endocrinol 1997;137:670-674
10. Kelestimur F, Sahin Y, Ayata D, Tutus A. The prevalence of non-classic adrenal hyperplasia due to 11 □-hydroxylase deficiency among hirsute women in a Turkish population. Clin Endocrinol 1996;45:381-384
11. Unluhizarci K, Gokce C, Atmaca H, Bayram F, Kelestimur F. A detailed investigation of hirsutism in a Turkish population: Idiopathic hyperandrogenemia as a perplexing issue. Exp Clin Endocrinol Diabetes 2004;112:504-509
12. Rosler A, Leiberman E, Coen T. High frequency of congenital adrenal hyperplasia (classic 11 beta-hydroxylase deficiency) among Jews from Morocco. Am J Med Genet 1992;42:827-834
13. Carmina E, Malizia G, Pagano M, Janni A. Prevalence of late-onset 11 beta-hydroxylase deficiency in hirsute patients J Endocrinol Invest 1988;11:595-598
14. Carbunaru G, Prasad P, Scoccia B, Shea P, Hopwood N, Ziai F, Chang YT, Myers SE, Mason JI, Pang S. The hormonal phenotype of non-classic 3 beta hydroxysteroid dehydrogenase (HSD3B2) deficiency in hyperandrogenic females is associated with insulin-resistant polycystic ovary syndrome and is not variant of inherited HSD3B2 deficiency. J Clin Endocrinol Metab 2004;89:783-794
15. Tajima T, Fujieda K, Nakae J, Toyoura T, Shimozawa K, Kusuda S, Goji K, Nagashima T, Cutler GB Jr. Molecular basis of nonclassical steroid 21-hydroxylase deficiency detected by neonatal mass screening in Japan. J Clin Endocrinol Metab 1997;82:2350-2356
16. Kelestimur F. Hirsutism of adenal origin in adolescents: consequences in adults. J Ped Endocrinol Metab 2001;14:1309-1315
17. Kelestimur F, Sahin Y. Alternate pathway 17,20-lyase enzyme activity in the adenals is enhanced in patients with polycystic ovary syndrome Fertil Steril 1999;71:1071-1078
18. Azziz R, Dewailly D, Owerbach D. Clinical Review 56: Non-classic adrenal hyperplasia: current concept. J Clin Endocrinol Metab 1994;78:810-815
19. Moran C, Azziz R, Carmina E, Dewailly D, Fruzzetti F, Ibanez L, Knochenhauer ES, Marcondes JA, Mendonca BB, Pignatelli D, Pugeat M, Rohmer V, Speiser PW, Witchel FS. 21-Hydroxylase-deficient nonclassic adrenal hyperplasia is a progressive disorder: a multicenter study. Am J Obstet Gynecol 2000;183:1468-1474
20. Tusie-Luna MT, Speiser PW, Dumic M, New MI, White PC. A mutation (Pro-30 to Leu) in CYP21 represents a potential nonclassic steroid 21-hydroxylase deficiency allele. Mol Endocrinol 1991;5:685-692
21. Speiser PW, Serrat J, New MI, Gertner JM. Insulin sensitivity in adrenal hyperplasia due to nonclassical steroid 21-hydroxylase deficiency. J Clin Endocrinol Metab 1992;75:1421-1424
22. Speiser PW, White PC. Congenital adrenal hyperplasia. N Engl J Med 2003;349:776-788
23. Kater CE, Biglieri EG, Wajchenberg B. Effects of continued adrenocorticotropin stimulation on the mineralocorticoid hormones in classical and nonclassical simple virilizing types of 21-hydroxylase deficiency. J Clin Endocrinol Metab 1985;60:1057-1062
24. Trakasis E, Laggas D, salamalekis E, Creatsas G. 21-hydroxylase deficiency: From molecular genetics to clinical presentation. J Endocrinol Invest 2005;28:187-192
25. Knochenhauer ES, Cortet-Rudelli C, Cunnigham RD, Conway-Myers BA, Dewailly D, Aziz R. Carriers of 21-hydroxylase deficiency are not at increased risk for hyperandrogenism. J Clin Endocrinol Metab 1997;82:479-485
26. Witchel SF, Lee PA, Suda-Hartman M, Hoffman EP. Hyperandrogenism and manifesting heterozygotes for 21-hydroxylase deficiency. Biochem Mol Med 1997;62:151-158
27. Azziz R, Hincapie LA, Knochenhauer ES, Dewailly D, Fox L, Boots R. Screening for 21-hydroxylase-deficient nonclassic adrenal hyperplasia among hyperandrogenic women: a prospective study. Fertil Steril 1999;72:915-925
28. Siegel SF, Finegold DN, Lanes R, Lee PA. ACTH stimulation tests and plasma dehydroepiandrosterone sulfate levels in women with hirsutism. N Engl J Med 1990;323:849-854
29. Escobar-Morreale HF, Millan JLS, Smith RR, Sancho J, Witchel SF. The presence of the 21-hydroxylase deficiency carrier status in hirsute women: phenotype-genotype correlations. Fertil Steril 1999;72:629-638
30. Unluhizarci K, Kelestimur F, Güven M, Bayram F, Çolak R. The value of low dose (1 μg) ACTH stimulation test in the investigation of non-classic adrenal hyperplasia due to 11-β OH deficiency. Exp Clin Endocrinol Diabetes 2000;110:381-385
31. Spritzer P, Billaud L, Thalabard JC, Birman P, Mowszowicz I, Raux-Demay MC, Kuttenn F, Mauvais-Jarvis P. Cyproterone acetate versus hydrocortisone treatment in late-onset adrenal hyperplasia. J Clin Endocrinol Metab 1990;70:642-646
32. Carmina E, Lobo RA. Ovarian suppression reduces clinical and endocrine expression of late-onset congenital adrenal hyperplasia due to 21-OH deficiency. Fertil Steril 1994;62:738-742
33. Weintrob N, Dickerman Z, Sprecher E, Galatzer A, Pertzelan A. Nonclassical 21-hydroylase deficiency in infancy and childhood: the effect of time of initiation of therapy and final height. Eur J Endocrinol 1997;136:188-195
34. New MI, Gertner JM, Chir B, Speiser PW, Del Balzo P. Growth and final height in classical and nonclassical 21-hydroylase deficiency. Acta Paediatr Jpn 1998;30:79-88
35. White PC, Speiser PW. Congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Endocrine Rev 2000;21:245-291